List of leading inspection concept stocks in COVID-19
Mike Audi: Xiamen Mike Audi Medical Laboratory Co., Ltd., a subsidiary of the Medical Division, undertakes part of COVID-19 nucleic acid detection business in Xiamen; Xiamen Maiaodi Laboratory, a subsidiary of the company, has the qualification of nucleic acid detection and is one of the designated institutions for virus nucleic acid detection in Xiamen.
New Open Source: At present, New Open Source has three subsidiaries in the medical field, namely Wuhan Hull, Changsha Shan Zhi and Shanghai Jingneng. At the same time, it is acquiring a number of domestic and foreign medical companies, whose business mainly involves women's health (diagnosis and treatment of cervical cancer and breast cancer) and precision medicine (molecular diagnosis and genetic testing).
Changhong Technology: reaction cup products and novel coronavirus test kits (such as gene chips and kit products).
Runda Medical: Shanghai Runda Jiarong, a holding subsidiary, has developed two novel coronavirus testing products with R&D partners Jingnajie and Hanghang based on its clinical advantages in IVD research; The kit developed in cooperation with Beijing Najie is equipped with virus inactivation preservation solution, which can be directly added to PCR reaction solution for online detection without accounting and extraction. 96 samples can be detected at a time, and the report will be issued 80- 100 minutes after adding samples. The kit developed in cooperation with Hangzhou Pilotage Gene is equipped with virus inactivation preservation solution. After nucleic acid extraction, the sample was directly added to the digital PCR reaction solution for computer detection, and the reporting time was 160 minutes.
Huachang Chemical: Nanjing Shihe Gene and Practical Medicine, invested by Suzhou Ruihua Investment Partnership (company holding 10%), successfully developed COVID-19 nucleic acid detection kit.